ATYPICAL RESPONDERS LANDSCAPE REVIEW ∙ OCTOBER, 2017 45 42. Nechuta, S., et al., Comorbidities and breast cancer survival: a report from the Shanghai Breast Cancer Survival Study. Breast Cancer Res Treat, 2013. 139(1): p. 227-35. 43. Franks, A.L. and J.E. Slansky, Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancer. Anticancer Res, 2012. 32(4): p. 1119-36. 44. Gong, Z., et al., Diabetes, metformin and incidence of and death from invasive cancer in postmenopausal women: Results from the women’s health initiative. Int J Cancer, 2016. 138(8): p. 1915-27. 45. Ponde, N.F., M. Lambertini, and E. de Azambuja, Twenty years of anti-HER2 therapy- associated cardiotoxicity. ESMO Open, 2016. 1(4): p. e000073. 46. Sogaard, M., et al., The impact of comorbidity on cancer survival: a review. Clin Epidemiol, 2013. 5(Suppl 1): p. 3-29. 47. Jones, L.W. and C.M. Alfano, Exercise-oncology research: past, present, and future. Acta Oncol, 2013. 52(2): p. 195-215. 48. Kushi, L.H., et al., Lifestyle factors and survival in women with breast cancer. J Nutr, 2007. 137(1 Suppl): p. 236s-242s. 49. Cohen, E.E., et al., Phase I studies of sirolimus alone or in combination with pharmacokinetic modulators in advanced cancer patients. Clin Cancer Res, 2012. 18(17): p. 4785-93. 50. Holmes, M.D., et al., Physical activity and survival after breast cancer diagnosis. JAMA, 2005. 293(20): p. 2479-86. 51. Pierce, J.P., et al., Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity. J Clin Oncol, 2007. 25(17): p. 2345-51. 52. Betof, A.S., et al., Modulation of murine breast tumor vascularity, hypoxia and chemotherapeutic response by exercise. J Natl Cancer Inst, 2015. 107(5). 53. Elwood, P.C., et al., Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published Studies. PLoS One, 2016. 11(4): p. e0152402. 54. Mohr, S.B., et al., Meta-analysis of vitamin D sufficiency for improving survival of patients with breast cancer. Anticancer Res, 2014. 34(3): p. 1163-6. 55. Greenlee, H., et al., Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer. J Natl Cancer Inst Monogr, 2014. 2014(50): p. 346-58.